Ventyx Biosciences Inc (VTYX)
4.675
-0.06
(-1.37%)
USD |
NASDAQ |
May 22, 16:00
4.655
-0.02
(-0.43%)
After-Hours: 20:00
Ventyx Biosciences Net Income (TTM): -192.60M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -192.60M |
December 31, 2023 | -192.96M |
September 30, 2023 | -181.42M |
June 30, 2023 | -157.86M |
March 31, 2023 | -124.62M |
December 31, 2022 | -108.43M |
Date | Value |
---|---|
September 30, 2022 | -90.98M |
June 30, 2022 | -73.29M |
March 31, 2022 | -68.83M |
December 31, 2021 | -83.75M |
September 30, 2021 | -82.68M |
June 30, 2021 | -77.06M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-192.96M
Minimum
Dec 2023
-68.83M
Maximum
Mar 2022
-119.54M
Average
-99.70M
Median
Net Income (TTM) Benchmarks
Anavex Life Sciences Corp | -40.59M |
CERo Therapeutics Holdings Inc | -- |
Avinger Inc | -19.19M |
Checkpoint Therapeutics Inc | -52.32M |
RAPT Therapeutics Inc | -118.05M |